C Leiendecker‐Foster

542 total citations
15 papers, 388 citations indexed

About

C Leiendecker‐Foster is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C Leiendecker‐Foster has authored 15 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C Leiendecker‐Foster's work include Iron Metabolism and Disorders (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Hormonal Regulation and Hypertension (4 papers). C Leiendecker‐Foster is often cited by papers focused on Iron Metabolism and Disorders (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Hormonal Regulation and Hypertension (4 papers). C Leiendecker‐Foster collaborates with scholars based in United States and Canada. C Leiendecker‐Foster's co-authors include Barry R. Davis, Donna K. Arnett, Eric Boerwinkle, Charles E. Ford, John H. Eckfeldt, Henry R. Black, James C. Barton, J H Eckfeldt, Michael B. Miller and Paul C. Adams and has published in prestigious journals such as Circulation, Clinical Chemistry and Clinical Gastroenterology and Hepatology.

In The Last Decade

C Leiendecker‐Foster

15 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Leiendecker‐Foster United States 11 144 125 123 118 111 15 388
Agustin Melian United States 6 67 0.5× 25 0.2× 196 1.6× 51 0.4× 25 0.2× 10 495
Amy M. Meadowcroft United States 9 287 2.0× 94 0.8× 62 0.5× 28 0.2× 10 0.1× 21 471
Ilaria Tenuti Italy 6 156 1.1× 113 0.9× 21 0.2× 22 0.2× 78 0.7× 8 320
Nantarat Komanasin Thailand 9 113 0.8× 31 0.2× 31 0.3× 67 0.6× 33 0.3× 25 335
Fumio Nanishi Japan 12 38 0.3× 21 0.2× 31 0.3× 61 0.5× 36 0.3× 31 313
T Kitajima Japan 7 25 0.2× 60 0.5× 158 1.3× 237 2.0× 9 0.1× 13 434
Elisabetta Trabetti Italy 8 62 0.4× 18 0.1× 95 0.8× 286 2.4× 14 0.1× 8 452
Nosratola D. Vaziri United States 6 52 0.4× 18 0.1× 77 0.6× 68 0.6× 48 0.4× 8 403
Z. Sangiorgi Italy 7 38 0.3× 16 0.1× 88 0.7× 93 0.8× 48 0.4× 16 408

Countries citing papers authored by C Leiendecker‐Foster

Since Specialization
Citations

This map shows the geographic impact of C Leiendecker‐Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Leiendecker‐Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Leiendecker‐Foster more than expected).

Fields of papers citing papers by C Leiendecker‐Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Leiendecker‐Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Leiendecker‐Foster. The network helps show where C Leiendecker‐Foster may publish in the future.

Co-authorship network of co-authors of C Leiendecker‐Foster

This figure shows the co-authorship network connecting the top 25 collaborators of C Leiendecker‐Foster. A scholar is included among the top collaborators of C Leiendecker‐Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Leiendecker‐Foster. C Leiendecker‐Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Barton, James C., et al.. (2009). Relationships of serum free thyroxine and erythrocyte measures in euthyroid HFE C282Y homozygotes and control subjects: the HEIRS Study. International Journal of Laboratory Hematology. 32(3). 282–287. 3 indexed citations
2.
Adams, Paul C., James S. Pankow, James C. Barton, et al.. (2009). HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol. Circulation Cardiovascular Genetics. 2(1). 34–37. 19 indexed citations
3.
Acton, Ronald T., James C. Barton, Lori A. Passmore, et al.. (2008). Accuracy of Family History of Hemochromatosis or Iron Overload: The Hemochromatosis and Iron Overload Screening Study. Clinical Gastroenterology and Hepatology. 6(8). 934–938. 11 indexed citations
4.
Rt, Acton, James C. Barton, P C Adams, et al.. (2007). A genome‐wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study. Clinical Genetics. 71(6). 518–529. 12 indexed citations
5.
Adams, Paul C., David M. Reboussin, James C. Barton, et al.. (2007). Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study. International Journal of Laboratory Hematology. 30(4). 300–305. 6 indexed citations
6.
Lynch, Amy I., Donna K. Arnett, Barry R. Davis, et al.. (2007). Sex‐Specific Effects of AGT‐6 and ACE I/D on Pulse Pressure After 6 Months on Antihypertensive Treatment: The GenHAT Study. Annals of Human Genetics. 71(6). 735–745. 12 indexed citations
7.
Davis, Barry R., Donna K. Arnett, Eric Boerwinkle, et al.. (2006). Antihypertensive therapy, the α-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study. The Pharmacogenomics Journal. 7(2). 112–122. 33 indexed citations
8.
Rt, Acton, et al.. (2006). Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.. PubMed. 16(4). 815–21. 31 indexed citations
9.
Barton, James C., Ronald T. Acton, Fitzroy W. Dawkins, et al.. (2005). Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study. Genetic Testing. 9(3). 231–241. 59 indexed citations
10.
Arnett, Donna K., Barry R. Davis, Charles E. Ford, et al.. (2005). Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment. Circulation. 111(25). 3374–3383. 101 indexed citations
12.
Province, Michael A., S C Hunt, C Leiendecker‐Foster, et al.. (2000). Association between the  -adducin gene and hypertension in the HyperGEN study. American Journal of Hypertension. 13(6). 710–718. 50 indexed citations
13.
Witowski, Nancy E., C Leiendecker‐Foster, Norman P. Gerry, Ronald C. McGlennen, & George Bárány. (2000). Microarray-Based Detection of Select Cardiovascular Disease Markers. BioTechniques. 29(5). 936–944. 13 indexed citations
15.
Leiendecker‐Foster, C & Esther F. Freier. (1981). Improved simultaneous gas-chromatographic analysis for homovanillic acid and vanillylmandelic acid in urine.. Clinical Chemistry. 27(12). 2029–2032. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026